Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,325,346 papers from all fields of science
Search
Sign In
Create Free Account
Cross-Presentation
Known as:
Cross Presentation
Transfer of exogenous ANTIGEN to the ANTIGEN-PRESENTING CELLS for presentation to naive CD8-POSITIVE LYMPHOCYTES.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Cross-Priming
Narrower (1)
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
HLA-F and MHC-I Open Conformers Cooperate in a MHC-I Antigen Cross-Presentation Pathway
J. Goodridge
,
N. Lee
,
+6 authors
D. Geraghty
Journal of Immunology
2013
Corpus ID: 11806454
Peptides that are presented by MHC class I (MHC-I) are processed from two potential sources, as follows: newly synthesized…
Expand
Review
2011
Review
2011
Harnessing dendritic cells in cancer.
L. Apetoh
,
C. Locher
,
F. Ghiringhelli
,
G. Kroemer
,
L. Zitvogel
Seminars in Immunology
2011
Corpus ID: 19410717
Highly Cited
2009
Highly Cited
2009
Contribution of Direct and Cross-Presentation to CTL Immunity against Herpes Simplex Virus 11
Adan Chari Jirmo
,
Claus-Henning Nagel
,
C. Bohnen
,
B. Sodeik
,
G. Behrens
Journal of Immunology
2009
Corpus ID: 25228839
Dendritic cells (DC), which can be subdivided into different phenotypic and functional subsets, play a pivotal role in the…
Expand
Review
2004
Review
2004
Pathways for antigen cross presentation
P. Guermonprez
,
S. Amigorena
Springer Seminars in Immunopathology
2004
Corpus ID: 8315457
Dendritic cells (DCs) have the unique ability to capture cellular tissue antigens, and to present them on MHC class I molecules…
Expand
2003
2003
The ins and outs of cross-presentation
K. Rock
Nature Immunology
2003
Corpus ID: 37791508
A recent pair of Nature papers potentially provide some of the missing pieces to the puzzle of how antigens are cross-presented.
Highly Cited
2003
Highly Cited
2003
Endogenous neosynthesis vs. cross-presentation of viral antigens for cytotoxic T cell priming
S. Freigang
,
D. Egger
,
K. Bienz
,
H. Hengartner
,
R. Zinkernagel
Proceedings of the National Academy of Sciences…
2003
Corpus ID: 10330015
Induction of antiviral cytotoxic T lymphocytes (CTLs) has been proposed to require cross-presentation of viral antigens derived…
Expand
2003
2003
A dynamical perspective of CTL cross-priming and regulation: implications for cancer immunology.
D. Wodarz
,
V. Jansen
Immunology Letters
2003
Corpus ID: 578115
Highly Cited
2003
Highly Cited
2003
Cutting Edge: Efficient MHC Class I Cross-Presentation during Early Vaccinia Infection Requires the Transfer of Proteasomal Intermediates between Antigen Donor and Presenting Cells 1
A. Serna
,
M. C. Ramírez
,
Anna Soukhanova
,
L. Sigal
Journal of Immunology
2003
Corpus ID: 22595748
Priming of CD8+ T cells requires presentation of short peptides bound to MHC class I molecules of professional APCs. Cross…
Expand
Highly Cited
2001
Highly Cited
2001
Factors influencing cross‐presentation of non‐self antigens expressed from recombinant adeno‐associated virus vectors
A. Sarukhan
,
C. Soudais
,
O. Danos
,
K. Jooss
Journal of Gene Medicine
2001
Corpus ID: 34121506
We have previously demonstrated that recombinant adeno‐associated virus vectors expressing the influenza virus hemagglutinin…
Expand
Highly Cited
1999
Highly Cited
1999
Delayed clearance of apoptotic lymphoma cells allows cross‐presentation of intracellular antigens by mature dendritic cells
P. Rovere
,
M. Sabbadini
,
+5 authors
A. Manfredi
Journal of Leukocyte Biology
1999
Corpus ID: 1194672
Single cells are deleted from the midst of living tissue during normal turnover and embryogenesis. This event is not associated…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE